€
5.30
May 20
Business Description
Lifecore Biomedical Inc
NAICS : 325412
SIC : 2833
ISIN : US5147661046
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.17 | |||||
Equity-to-Asset | -0.02 | |||||
Debt-to-Equity | -26.63 | |||||
Debt-to-EBITDA | -3 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.43 | |||||
Beneish M-Score | -3.45 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14.4 | |||||
3-Year EBITDA Growth Rate | -64.8 | |||||
3-Year EPS without NRI Growth Rate | -56.6 | |||||
3-Year FCF Growth Rate | 4.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 16.74 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.61 | |||||
9-Day RSI | 32.08 | |||||
14-Day RSI | 38.09 | |||||
6-1 Month Momentum % | -12.03 | |||||
12-1 Month Momentum % | 21.88 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.39 | |||||
Quick Ratio | 1.35 | |||||
Cash Ratio | 0.49 | |||||
Days Inventory | 181.5 | |||||
Days Sales Outstanding | 95.15 | |||||
Days Payable | 63.92 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 12.12 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 20.52 | |||||
Operating Margin % | -15.64 | |||||
Net Margin % | -73.6 | |||||
FCF Margin % | -28.24 | |||||
ROE % | -172.33 | |||||
ROA % | -37.45 | |||||
ROIC % | -8.3 | |||||
ROC (Joel Greenblatt) % | -25.95 | |||||
ROCE % | -31.89 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 9.94 | |||||
PS Ratio | 1.31 | |||||
EV-to-EBIT | -5.41 | |||||
EV-to-EBITDA | -7.32 | |||||
EV-to-Forward-EBITDA | 15.13 | |||||
EV-to-Revenue | 2.03 | |||||
EV-to-Forward-Revenue | 2.22 | |||||
EV-to-FCF | -7.06 | |||||
Price-to-Median-PS-Value | 1.74 | |||||
Earnings Yield (Greenblatt) % | -18.48 | |||||
FCF Yield % | -21.47 | |||||
Forward Rate of Return (Yacktman) % | 22.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Lifecore Biomedical Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 130.113 | ||
EPS (TTM) (€) | -3.124 | ||
Beta | -0.54 | ||
Volatility % | 109.02 | ||
14-Day RSI | 38.09 | ||
14-Day ATR (€) | 0.150897 | ||
20-Day SMA (€) | 5.84 | ||
12-1 Month Momentum % | 21.88 | ||
52-Week Range (€) | 4.5 - 9.75 | ||
Shares Outstanding (Mil) | 30.55 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Lifecore Biomedical Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Lifecore Biomedical Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Lifecore Biomedical Inc Frequently Asked Questions
What is Lifecore Biomedical Inc(FRA:LDE)'s stock price today?
When is next earnings date of Lifecore Biomedical Inc(FRA:LDE)?
Does Lifecore Biomedical Inc(FRA:LDE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |